LRP5 Antibody
-
中文名稱：LRP5兔多克隆抗體
-
貨號：CSB-PA255528
-
規(guī)格：￥1100
-
圖片：
-
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using CSB-PA255528(LRP5 Antibody) at dilution 1/55, on the right is treated with synthetic peptide. (Original magnification: ×200) -
The image on the left is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using CSB-PA255528(LRP5 Antibody) at dilution 1/55, on the right is treated with synthetic peptide. (Original magnification: ×200)
-
-
其他：
產(chǎn)品詳情
-
Uniprot No.：
-
基因名：
-
別名：BMND1 antibody; EVR1 antibody; EVR4 antibody; HBM antibody; Low density lipoprotein receptor related protein 5 antibody; Low density lipoprotein receptor related protein 7 antibody; Low-density lipoprotein receptor-related protein 5 antibody; LR3 antibody; LRP-5 antibody; Lrp5 antibody; LRP5_HUMAN antibody; LRP7 antibody; OPPG antibody; OPS antibody; OPTA1 antibody; Osteoporosis pseudoglioma syndrome antibody; VBCH2 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse
-
免疫原：Synthetic peptide of Human LRP5
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產(chǎn)品提供形式：Liquid
-
應用范圍：ELISA,IHC
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:2000-1:10000 IHC 1:50-1:200 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關產(chǎn)品
靶點詳情
-
功能：Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins. Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration. In particular, may play an important role in the development of the posterior patterning of the epiblast during gastrulation. During bone development, regulates osteoblast proliferation and differentiation thus determining bone mass. Mechanistically, the formation of the signaling complex between Wnt ligand, frizzled receptor and LRP5 coreceptor promotes the recruitment of AXIN1 to LRP5, stabilizing beta-catenin/CTNNB1 and activating TCF/LEF-mediated transcriptional programs. Acts as a coreceptor for non-Wnt proteins, such as norrin/NDP. Binding of norrin/NDP to frizzled 4/FZD4-LRP5 receptor complex triggers beta-catenin/CTNNB1-dependent signaling known to be required for retinal vascular development. Plays a role in controlling postnatal vascular regression in retina via macrophage-induced endothelial cell apoptosis.
-
基因功能參考文獻：
- our results demonstrated an association of the T allele for the LRP5 4037C>T polymorphism with type 1 diabetes mellitus susceptibility in a Brazilian population, moreover the possible relation in the progressive failure of glycemic control. PMID: 30304114
- This is the first study to report a group of patients with digenic familial exudative vitreoretinopathy (FEVR). In most affected eyes, the stage was more severe than stage 3. We speculate that the phenotype of FEVR is more severe in patients with digenic rather than monogenic variants of FEVR-related genes. PMID: 30097784
- These findings expand the mutation spectrums of ABCA4 and LRP5, and will be valuable for genetic counseling and development of therapeutic interventions for patients with Familial exudative vitreoretinopathy. PMID: 29207047
- Data suggest that the risk of type 2 diabetes mellitus (T2DM) may be associated with interactions between the low-density lipoprotein receptor-related protein 5 (LRP5) gene and overweight and obesity. PMID: 28067456
- The data do not support the hypothesis that HBM-causing LRP5 mutations, associated with increased Wnt signaling, improve glucose metabolism in humans. However, it does appear that LRP5 variants may affect LDL metabolism, a major risk factor for coronary artery disease. PMID: 28283687
- In conclusion, the LRP5 mutation influences cell proliferation through the Wnt signaling pathway, thereby reducing the number of supporting cells and hair cells and leading to nonsyndromic hearing loss in this Chinese family. PMID: 28677207
- LRP5 might be an important genetic marker contributing to bone mass accrual early in life. PMID: 28028632
- We identified two novel heterozygous deletion mutations [LRP5, c.4053 DelC (p.Ile1351IlefsX88); TSPAN12, EX8Del] using targeted NGS as a causative mutation for Familial exudative vitreoretinopathy (FEVR). PMID: 28867931
- A novel heterozygous mutation (p.N198Y) in LRP5 was identified in a patient with significantly increased bone mineral density. PMID: 28893644
- The presence of GIIA in the LRP5 complex pinpoints a potential functional connection with PRKCSH. Interestingly, all three PLD-associated protein complexes included filamin A (FLNA), a multifunctional protein described to play a role in ciliogenesis as well as canonical Wnt signalling. PMID: 28973524
- Phenotypic variability was observed in the familial case and molecular analysis identified a novel homozygous c.1145C>T, p.(Pro382Leu) variant in both sibs. Homozygosity for the c.442C>T, p.(Gln148*) variant was also demonstrated in a separate case. PMID: 29131652
- LRP5 (rs556442) had a significant influence on trigylceride (TG) levels in unadjusted analysis and when adjusted for interacting factors. Higher TG levels were observed in AA/AG genotype of rs566442 in comparison to GG genotype (OR = 2.028, 95% CI = 0.997-4.127, p = 0.049). PMID: 28139941
- The detection rate for mutations in the three known genes was 23%. Mutations in LRP5 and TSPAN12 were more frequent, accounting for 10% and 8% PMID: 29181528
- To our knowledge, these are the first two cases of the syndrome described in Italy. Genetic testing proved to be fundamental for definition of the syndrome and confirms the importance of early detection of LRP5 variants for management of systemic features of the disease in patients and carrier relatives. PMID: 28145787
- VAP1 cleaved the extracellular region of LRP5. This cleavage removes four inhibitory beta-propeller structures, resulting in activation of LRP5/6. PMID: 28425175
- wild-type and all five mutant LRP5 proteins were assayed for the ability to activate the Norrin/beta-catenin pathway by established luciferase reporter assays, and all mutants failed to activate the pathway. PMID: 28420620
- This study did not identify LRP5 polymorphisms as a risk factor for osteoporosis in Thai menopausal women. PMID: 27582019
- We identified four novel LRP5 missense mutations in these FEVR families: c.C1042T (p.R348W), c.G1141A (p.D381N), c.C1870T (p.R624W), and c.A4550G (p.Y1517C). All four of these LRP5 mutations led to significant reduction of enzymatic activity with response to NORRIN. Our findings expand the mutational spectrum of FEVR in the Indian population and provide some guidelines in clinical diagnosis. PMID: 27228167
- In this study, the splice site mutation c.2827thorn1G > A found in LRP5 (603506) gene is thought to cause microphthalmia in this family. PMID: 28111184
- A genetic evaluation of the known genes associated with familial exudative vitreoretinopathy (FEVR) revealed a novel variant in the LRP5 gene that co-segregated with the phenotype in the family. PMID: 27486893
- Meta-analysis indicates that the LRP5 Ala1330Val polymorphism may not be correlated with fracture susceptibility. PMID: 27051030
- Independently or combined with APOE, LRP5 polymorphisms may lead to dyslipidemia and are associated with generalized aggressive periodontitis. Dyslipidemia may be a risk indicator for generalized aggressive periodontitis in the Chinese population. Furthermore, two LRP5 polymorphisms (rs682429 and rs312016) might be useful for identifying subjects at higher risk of generalized aggressive periodontitis. PMID: 25329009
- miR-23a plays an inhibitory role in osteogenic differentiation of hBMSCs, which may act by targeting LRP5 PMID: 26774446
- The authors report a case of familial exudative vitreoretinopathy in the spectrum of osteoporosis pseudoglioma syndrome associated with novel mutations of the LRP5 and TSPAN12 genes that resulted in a phenotype similar to bilateral persistent fetal vasculature. PMID: 27007396
- LRP5 is a novel anti-inflammatory macrophage marker that positively regulates migration, phagocytosis, lipid uptake and metabolism. PMID: 26739212
- LRP5 is a signature of the anti-inflammatory defensive phenotype of macrophages. PMID: 26666179
- we identified a total of four different LRP5 variants that were predicted to be pathogenic by in silico tools. One ADPKD patient has a positive family history for ADPKD and variant LRP5 segregated with the disease. PMID: 25920554
- finding corroborates the relationship between LRP5 genotype and bone phenotype in postmenopausal women, however, the complete mechanism of this relationship requires further investigations. PMID: 25762437
- This study show LRP5 polymorphism may associate with body composition and bone mineral density in Iranian children. PMID: 25515155
- Lrp5 controls glucose uptake and growth of MDA-MB-231 human breast cancer cells. PMID: 26711269
- Data show that LDL receptor-related protein 5 (LRP5) gain-of-function mutations do not activate beta-catenin signaling in osteoblasts. PMID: 26681532
- Molecular testing identified biallelic lipoprotein receptor-related protein 5 (LRP5) mutations (NM_002335.3:c. [889dupA]; [2827 + 1G > A]) confirming a diagnosis of osteoporosis-pseudoglioma (OPPG) syndrome. PMID: 25945592
- Lrp5 binds to Frizzled, preventing Frz-regulated non-canonical Wnt pathway activation and further non-canonical pathway-mediated tumour metastasis. PMID: 25902418
- Reciprocally, a low bone mineral density-associated common LRP5 allele correlated with increased abdominal adiposity. PMID: 25651180
- no association of single nucleotide polymorphisms and type 2 diabetes mellitus susceptibility in Chinese population PMID: 25863010
- This is the first study to suggest the genetic influence of LRP5 A1330V polymorphism on bone mineral density in COPD patients, independent of the development of emphysema. PMID: 25392953
- Although AFFs have been reported in other rare bone diseases, this is the first in a genetic condition of primary osteoblast dysfunction. The relatively low bone turnover observed, and knowledge of LRP5 function PMID: 25384351
- No LRP5 variant was found to be associated with type 2 diabetes mellitus in Han Chinese, but haplotype TT was found to be associated with type 2 diabetes mellitus . PMID: 26248735
- Serum levels of Wnt inhibitors are not changed in individuals with high bone mass causing mutations in LRP5. PMID: 24927689
- Among the patients with pathogenic mutations detected, FZD4 mutations accounted for the largest proportion of autosomal inheritance FEVR cases (13/18 patients, 72.2%), followed by LRP5 (4/18 patients, 22.2%) and TSPAN12 (1/18 patients, 5.6%). PMID: 26244290
- Our findings indicate that LRP5 plays an essential role in osteoarthritis cartilage destruction PMID: 24479426
- mechanism of LRP protein action in the process of bone tissue metabolism and etiology of osteoporosis. PMID: 26117992
- These results suggest that there is a modest effect of the LRP5 rs3736228 C>T on the increased susceptibility of bone fracture and osteoporosis. PMID: 25580429
- These results underscore the significance of the LRP5 gene in bone metabolism and emphasize the significance of the replication of previous results in independent cohorts. PMID: 24337955
- The Ala1330Val polymorphism in LRP5 is weakly associated with lower lumbar spine bone density in Tunisian post-menopausal women. PMID: 24885293
- The A1330V polymorphism of LRP5 is possibly correlated with response to alendronate treatment in Chinese women. PMID: 24897288
- evidence of lack of LRP5 mutations and of a putative HBM-causing mutation in DKK1 PMID: 24736728
- Circulating plasma sclerostin concentrations are increased in both LRP5 and non-LRP5 High bone mass patients compared with controls. PMID: 24606091
- LRP5 polymorphisms may be modestly associated with bone mineral density of the lumbar spine and the femur neck. PMID: 24376863
- Two new novel LRP5 mutations in Chinese patients with familial exudative vitreoretinopathy and mild reduced bone mineral density, were identified. PMID: 24715757
顯示更多
收起更多
-
相關疾病：Vitreoretinopathy, exudative 1 (EVR1); Vitreoretinopathy, exudative 4 (EVR4); Osteoporosis (OSTEOP); Osteoporosis-pseudoglioma syndrome (OPPG); High bone mass trait (HBM); Endosteal hyperostosis, Worth type (WENHY); Osteopetrosis, autosomal dominant 1 (OPTA1); Van Buchem disease 2 (VBCH2)
-
亞細胞定位：Membrane; Single-pass type I membrane protein. Endoplasmic reticulum.
-
蛋白家族：LDLR family
-
組織特異性：Widely expressed, with the highest level of expression in the liver and in aorta.
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
-
-
-
-
-
-
VDAC1 Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human, Mouse, Rat
